Published in Oncol Nurs Forum on September 01, 2008
Quality of life in men undergoing active surveillance for localized prostate cancer. J Natl Cancer Inst Monogr (2012) 1.49
The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs (2009) 1.41
Interdependent psychological quality of life in dyads adjusting to prostate cancer. Health Psychol (2011) 0.95
Differences in sleep disturbance and fatigue between patients with breast and prostate cancer at the initiation of radiation therapy. J Pain Symptom Manage (2011) 0.93
Differences in symptom clusters identified using occurrence rates versus symptom severity ratings in patients at the end of radiation therapy. Cancer Nurs (2009) 0.89
Symptom clusters using the Spitzer quality of life index in patients with brain metastases--a reanalysis comparing different statistical methods. Support Care Cancer (2012) 0.83
Fatigue-based subgroups of breast cancer survivors with insomnia. Cancer Nurs (2009) 0.82
Cancer Related Fatigue and Quality of Life in Patients with Advanced Prostate Cancer Undergoing Chemotherapy. Biomed Res Int (2016) 0.76
Symptom Cluster Research With Biomarkers and Genetics Using Latent Class Analysis. West J Nurs Res (2016) 0.75
Transitions in Symptom Cluster Subgroups Among Men Undergoing Prostate Cancer Radiation Therapy. Cancer Nurs (2015) 0.75
Symptom clusters in adults with inflammatory bowel disease. Res Nurs Health (2017) 0.75
Symptom clusters in patients with bone metastases--a reanalysis comparing different statistical methods. Support Care Cancer (2012) 0.75
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res (2004) 4.15
Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol (2002) 4.13
Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol (2003) 4.11
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer (2007) 3.92
Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92
Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res (2009) 3.86
Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med (2013) 3.74
Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol (2003) 3.62
Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol (2013) 3.32
Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol (2002) 3.14
Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst (2002) 3.00
Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum (2007) 2.90
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82
Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res (2008) 2.81
The economic impact of chronic prostatitis. Arch Intern Med (2004) 2.74
Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst (2004) 2.66
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med (2008) 2.66
Spirituality influences health related quality of life in men with prostate cancer. Psychooncology (2006) 2.65
Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer (2010) 2.61
Quality-of-care indicators for early-stage prostate cancer. J Clin Oncol (2003) 2.44
Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol (2005) 2.41
Diffusion of surgical innovation among patients with kidney cancer. Cancer (2008) 2.38
Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut (2011) 2.38
Prostate cancer severity among low income, uninsured men. J Urol (2008) 2.38
Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg (2007) 2.28
Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst (2009) 2.28
β-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care (2012) 2.20
Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst (2010) 2.17
Comorbidity and competing risks for mortality in men with prostate cancer. Cancer (2011) 2.17
Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology (2009) 2.16
Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer (2007) 2.13
Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology (2009) 2.13
Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis. Cancer (2014) 2.07
Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link. Cancer (2014) 2.06
Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol (2011) 2.05
The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol (2006) 2.02
Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol (2011) 1.97
Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer (2009) 1.95
Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer. J Urol (2010) 1.94
Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer (2008) 1.89
Recurrence of high-risk bladder cancer: a population-based analysis. Cancer (2013) 1.87
Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst (2013) 1.86
Correlates of bother following treatment for clinically localized prostate cancer. J Urol (2010) 1.82
Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev Res (Phila) (2011) 1.77
Variation in continence and potency by definition. J Urol (2003) 1.75
Quality of care in patients with bladder cancer: a case report? Cancer (2011) 1.73
FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. Cancer Res (2010) 1.73
Differing perceptions of quality of life in patients with prostate cancer and their doctors. J Urol (2009) 1.72
Myeloid suppressor cell depletion augments antitumor activity in lung cancer. PLoS One (2012) 1.70
Variations in reconstruction after radical cystectomy. Cancer (2006) 1.69
Comorbidities, treatment and ensuing survival in men with prostate cancer. J Gen Intern Med (2011) 1.69
Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol (2006) 1.67
Electrochemical sensor for multiplex biomarkers detection. Clin Cancer Res (2009) 1.67
The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol (2006) 1.66
Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer (2004) 1.64
Urinary diversion and morbidity after radical cystectomy for bladder cancer. Cancer (2010) 1.63
Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database. J Urol (2003) 1.63
The demographic burden of urologic diseases in America. Urol Clin North Am (2009) 1.61
Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies. Arthritis Rheum (2005) 1.61
Improved prediction of long-term, other cause mortality in men with prostate cancer. J Urol (2011) 1.59
Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer. Arch Intern Med (2010) 1.59
Emergency department revisits for patients with kidney stones in California. Acad Emerg Med (2015) 1.56
Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications. J Urol (2007) 1.56
Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer (2010) 1.56
Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med (2010) 1.55
Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer. Cancer (2014) 1.55
Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer (2011) 1.55
Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol (2012) 1.55
Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol (2004) 1.52
Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer. Cancer (2013) 1.51
Health related quality of life in men with prostate cancer. J Urol (2003) 1.51
Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients. J Clin Oncol (2004) 1.50
Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol (2005) 1.50
Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res (2006) 1.50
Trends in the surgical management of stress urinary incontinence among female Medicare beneficiaries, 2002-2007. Urology (2013) 1.49
Quality of life in men undergoing active surveillance for localized prostate cancer. J Natl Cancer Inst Monogr (2012) 1.49
Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort. Urology (2011) 1.48
Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy. Prostate (2014) 1.47
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clin Cancer Res (2009) 1.47
The effect of concomitant prolapse repair on sling outcomes. J Urol (2008) 1.47
Green and black tea consumption and risk of stroke: a meta-analysis. Stroke (2009) 1.46
Hospice use and high-intensity care in men dying of prostate cancer. Arch Intern Med (2010) 1.45
Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS One (2010) 1.43
A survey of primary care physician practices in the diagnosis and management of women with interstitial cystitis/painful bladder syndrome. Urology (2010) 1.42